These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22293466)

  • 1. Common inherited mitochondrial DNA mutations and nucleoside reverse transcriptase inhibitor-induced severe hyperlactataemia in HIV-infected adults: an exploratory study.
    Arenas-Pinto A; Weller I; Ekong R; Grant A; Karstaedt A; Reiss P; Telisinghe L; Weber R; Bolhaar M; Bradman N; Ingram C
    Antivir Ther; 2012; 17(2):275-82. PubMed ID: 22293466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial).
    Feeney ER; Chazallon C; O'Brien N; Meiffrédy V; Goodall RL; Aboulker JP; Cooper DA; Yeni P; Mallon PW;
    HIV Med; 2011 Nov; 12(10):602-9. PubMed ID: 21599820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.
    van der Valk M; Casula M; Weverlingz GJ; van Kuijk K; van Eck-Smit B; Hulsebosch HJ; Nieuwkerk P; van Eeden A; Brinkman K; Lange J; de Ronde A; Reiss P
    Antivir Ther; 2004 Jun; 9(3):385-93. PubMed ID: 15259901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.
    Miró O; López S; Rodríguez de la Concepción M; Martínez E; Pedrol E; Garrabou G; Giralt M; Cardellach F; Gatell JM; Vilarroya F; Casademont J
    J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1550-5. PubMed ID: 15577406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
    Chêne G; Amellal B; Pédrono G; Gourlain K; Rancinan C; Journot V; Cotte L; Palmer P; Castro ND; Calvez V; Molina JM;
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):54-61. PubMed ID: 17263633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral blood mitochondrial DNA/nuclear DNA (mtDNA/nDNA) ratio as a marker of mitochondrial toxicities of stavudine containing antiretroviral therapy in HIV-infected Malawian patients.
    Kampira E; Dzobo K; Kumwenda J; van Oosterhout JJ; Parker MI; Dandara C
    OMICS; 2014 Jul; 18(7):438-45. PubMed ID: 24816082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater and more rapid depletion of mitochondrial DNA in blood of patients treated with dual (zidovudine+didanosine or zidovudine+zalcitabine) vs. single (zidovudine) nucleoside reverse transcriptase inhibitors.
    Reiss P; Casula M; de Ronde A; Weverling GJ; Goudsmit J; Lange JM
    HIV Med; 2004 Jan; 5(1):11-4. PubMed ID: 14731163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs.
    Moore RD; Keruly JC; Chaisson RE
    AIDS; 2001 Mar; 15(5):617-20. PubMed ID: 11316999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study.
    Hulgan T; Haas DW; Haines JL; Ritchie MD; Robbins GK; Shafer RW; Clifford DB; Kallianpur AR; Summar M; Canter JA
    AIDS; 2005 Sep; 19(13):1341-9. PubMed ID: 16103764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial DNA content of peripheral blood mononuclear cells in ART untreated & stavudine/zidovudine treated HIV-1-infected patients.
    Subashini D; Dinesha TR; Srirama RB; Boobalan J; Poongulali S; Chitra DA; Mothi SN; Solomon SS; Saravanan S; Solomon S; Balakrishnan P
    Indian J Med Res; 2018 Aug; 148(2):207-214. PubMed ID: 30381544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.
    Casula M; Weverling GJ; Wit FW; Timmermans EC; Stek M; Lange JM; Reiss P
    J Infect Dis; 2005 Nov; 192(10):1794-800. PubMed ID: 16235179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of mitochondrial DNA mutations in human immunodeficiency virus-infected patients treated with nucleoside-analogue reverse-transcriptase inhibitors.
    Martin AM; Hammond E; Nolan D; Pace C; Den Boer M; Taylor L; Moore H; Martinez OP; Christiansen FT; Mallal S
    Am J Hum Genet; 2003 Mar; 72(3):549-60. PubMed ID: 12587093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
    Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
    Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
    Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
    J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactic acidosis and symptomatic hyperlactataemia in a randomized trial of first-line therapy in HIV-infected adults in South Africa.
    Dlamini J; Ledwaba L; Mokwena N; Mokhathi T; Orsega S; Tsoku M; Kowo H; Proschan M; Khabo P; Maja P; Hadigan C
    Antivir Ther; 2011; 16(4):605-9. PubMed ID: 21685549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.
    Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA
    Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy.
    Lactic Acidosis International Study Group
    AIDS; 2007 Nov; 21(18):2455-64. PubMed ID: 18025882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in mitochondrial DNA copy number in blood cells from HIV-infected patients undergoing antiretroviral therapy.
    de Mendoza C; de Ronde A; Smolders K; Blanco F; Garcia-Benayas T; de Baar M; Fernández-Casas P; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):271-3. PubMed ID: 15117449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
    Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
    J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.